Durvalumab vs Pantoprazole

## Durvalumab vs Pantoprazole: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Pantoprazole**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Pantoprazole**: Proton pump inhibitor.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Pantoprazole — 1 hour.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Pantoprazole — C16H15F2N3O4S.

**Molecular Weight**: Durvalumab — N/A; Pantoprazole — 383.3710 g/mol.

**Type**: Durvalumab — Antibody; Pantoprazole — Small molecule.